Management of pregnancy-associated acute leukemia

WL Su; JY Liu; WY Kao

doi:10.12892/ejgo200303251

Article Menu

Export Article

EndNote (RIS)
BibTeX
RefMan
RefWorks

Article Data

Views 219
Dowloads 122

Reviews

Open Access

Management of pregnancy-associated acute leukemia

WL Su¹
JY Liu²
WY Kao^3,*,

¹Department of Internal Medicine, Tri-Service General Hospital, School of Public Health, National Defense Medical Center, Republic of China

²Department of Gynecology and Obstetrics, Tri-Service General Hospital, Republic of China

³Division of Hematology and Oncology, Tri-Service General Hospital, Taiwan, Republic of China

DOI: 10.12892/ejgo200303251 Vol.24,Issue 3-4,July 2003 pp.251-254

Published: 10 July 2003

*Corresponding Author(s): WY Kao E-mail:

PDF (544.85 kB) View Full-text

Abstract

Since leukocystosis and anemia are common findings in pregnancy, pathological alterations in hematopoesis, such as leukemias, can sometimes proceed undetected. Chemotherapy during pregnancy carries the risk of teratogenic effects on the fetus, and there is little data to guide chemotherapeutic regimens for leukemia during pregnancy. The following paper describes our experience in treating two women with acute leukemia during pregnancy and the immediate postpartum period, and reviews the relevant literature.

Keywords

Acute leukemia; Chemotherapy; Pregnancy

Cite and Share

WL Su,JY Liu,WY Kao. Management of pregnancy-associated acute leukemia. European Journal of Gynaecological Oncology. 2003. 24(3-4);251-254.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200303251

References

[1] McLain C.R Jr.: "Leukemia in pregnancy". Clinical Obstetrics & Gynecology, 1974, 17 (4), 185.

[2] Peleg D., Ben-Ami M.: "Lymphoma and leukemia complicating pregnancy". Obstet. Gynecol. Clinics No. Am., 1998, 25 (2), 365.

[3] Lynch S.R.: "The potential impact of iron Lympplementation during adolescence on iron status in pregnancy". J. Nutrit., 2000, I 30 (2S suppl.): 448S.

[4] Schwartz W.J. 3nd Thurnau G.R.: "Iron deficiency anemia m pregnancy". Clin. Obstet. Gynecol., 1995, 38 (3), 443.

[5] Branch D.W.: "Physiologic adaptations of pregnancy". Am. J Reprod. Immunol., 1992, 28 (3-4), 120.

[6] Zuazu J., Julia A., Sierra J. et al.: "Pregnancy outcome in hematologic malignancies". Cancer, 1991, 67 (3), 703.

[7] Camera A., Campanile M., Catalano D., Mattace Raso A., Rotoh B.: "Relapse of acute lymphoblastic leukemia during pregnancy" Eur. J. Gynaecol. Oncol., 1996; 17 (4), 303. Division of Statistics, Department of Health. Health and vital statistics, Taiwan area, R.O.C., 1999, 75.

[8] Sadural E. Smith LG. Jr.: "Hematologic malignancies during pregnancy". Clin. Ob.stet. Gynecol., 1995, 38 (3), 535

[9] Caligiuri M.A., Mayer R.J.: "Pregnancy and leukemia". Sem. Oncol., 1989, 16 (5), 388.

[10] Maloisel F., Dreyfus M., Neuhart D., Ritter J., Oberling F.: "Management of hematologic malignancies during pregnancy". J. Gynecologie，Obstetrique et Biologie de la Reproduction, 1996, 25 (6), 602.

[11] Aviles A., Niz J.: "Long-term follow-up of children born to mothers with acute leukemia during pregnancy". Med. Pediat Oncol., 1988, 16 (1), 3.

[12] Kawamura S., Tsushima K., Sakata Y.: "Pregnancy outcome in long-term survivors with adult acute leukemia, malignant lymphoma and breast cancer". lap. J. Cancer Chemothet:, 1996, 23 (7), 821.

[13] Lishner M., Koren G.: "Cancer chemotherapy dunng pregnancy Consortium of cancer in pregnancy evidence". Can. Fam. Phys.. 2001,47,41.

[14] Brell J., Kalaycio M.: "Leukemia in pregnancy". Sem. Oncol.. 2000, 27 (6), 667.

[15] Doll D.C.,R ingenberg Q.S.,Y arbro J.W.: "Management of cancer during pregnancy". Archives Inter. Med., 1988, 148 (9), 2058.

[16] Barber H.R.: "Fetal and neonatal effects of cytotoxic agents". Obstet. Gynecol., 1981, 58 (suppl.), 41S.

[17] Blatt J., MulvihiII J.J.,Z iegler J.L., Young R.C., Poplack D.G.: "Pregnancy outcome following cancer chemotherapy". Am. J. Med., 1980, 69 (6), 828.

[18] Boike G.M., Deppe G., Young J.D., Malone J.M. Jr., Malviya V.K., Sokol R.J.: "Chemotherapy in a pregnant rat model. 2.5-tluorouracil: nonlinear kinetics and placental transfer". Gynecol. Oncol., 1989, 34 (2), 191.

[19] Shamkhani H., Anderson L.M., Henderson C.E., Moskal T.J., Runowicz C.D., Dove L.F. et al.: "DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy". Reprod. Toxicol., 1994, 8 (3), 207.

[20] Hansen W.F., Fretz P., Hunter S.K., Yankowitz J.: "Leukemia in pregnancy and fetal response to multiagent chemotherapy" Obstet. Gynecol., 2001, 97 (5Pt 2), 809.

[21] Garcia L., Valcarcel M., Santiago-Borrero P.J.: "Chemotherapy during pregnancy and its effects on the fetus-neonatal myelosuppression: two case reports". J. Perinat., 1999, 19 (3), 230

[22] Buekers T.E., Lallas T.A.: "Chemotherapy in pregnancy". Obstet Gynecol. Clinics No. Am.. 1998, 25 (2), 323.

[23] Murray NA, Acolet D, Deane M, P rice J, Roberts IA. Fetal marrow suppression after maternal chemotherapy for leukemia Archives Dis. Childhood Fetal Neonatal Ed. 1994, 71 (3), F209.

[24] Feliu J., Juarez S., Ordonez A., Garcia-Paredes M.L., GonzalezBaron M., Montero J.M.: "Acute leukemia and pregnancy". Cancer, 1988, 61 (3), 580.

[25] Sweet D.L. Jr., Kinzie J.: "Consequences of radiotherapy and antineoplastic therapy for the fetus". J. Reprod. Med., 1976, 17 (4), 241.

[26] Mccredie K.B., Gehan E.A., Freireich E.J., Hewlett J.S., Coltman C.A. Jr., Hussein K.K. et al.: "Management of adult acute leukemia. A Southwest Oncology Group study". Cancer, 1983, 52 (6), 958.

[27] Ho C.L., Chen Y.C., Kao W.Y., Chao TY.: "Acute lymphoblastic leukemia in young adults: two chemotherapeutic protocols for the treatment of 46 patients". Chung Hua i Hsueh Tsa Chih - Chin. Med. J., 2000, 63 (1), 45.

[28] Styczynski J.,Pieters R., Huismans D.R., Schuurhuis G.J., Wysocki M., Veerman A.J.: "In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia". Br. J. Haematol.. 2000, 110 (4), 813.